Mesonephric-like adenocarcinoma of the ovary

Abstract Rationale: Mesonephric-like adenocarcinoma (MLA) from ovary is a very rare tumor which derives from mesonephric duct remnant of the female genital tract. Only six cases have been reported so far in the English literature. Patient concerns: A 29-year-old female patient was referred to the local hospital with a 20-day history of abdominal discomfort. Diagnoses: Pelvic ultrasound examination revealed a solid and cystic mass measuring 10 cm in diameter in the right adnexal area and a cystic mass measuring 5 cm in the left adnexal area. Postoperative pathology in the local hospital revealed suspected malignancy of the right ovary, and she was then transferred to our institution for definite diagnosis. The tumor mass was finally diagnosed as a primary MLA arising from the right ovary by histological and immunohistochemical examination in our institution. Interventions: The patient underwent laparoscopic right adnexectomy and removal of left ovarian cyst in the local institution. Then, she underwent a complete staging surgery including a total hysterectomy, left adnexectomy, pelvic plus para-aortic lymphadenectomy, and omentectomy in our hospital. In addition, she received four cycles of combination chemotherapy with carboplatin plus paclitaxel. Outcomes: There is no evidence of recurrence with 13 months of follow-up till now, and we are still following-up this patient. Lessons: MLA is an extremely uncommon malignancy with difficult diagnosis, unclear treatment and poor prognosis. Familiarizing with the clinical features and optimal management of this rare tumor may increase awareness of the disease among clinicians and pathologists, thus avoiding the misdiagnosis and mistreatment.

[1]  R. Murali,et al.  Cytologic features of upper gynecologic tract adenocarcinomas exhibiting mesonephric‐like differentiation , 2019, Cancer cytopathology.

[2]  N Montalvo,et al.  Mesonephric adenocarcinoma of the cervix: a case report with a three-year follow-up, lung metastases, and next-generation sequencing analysis , 2019, Diagnostic Pathology.

[3]  K. Hasegawa,et al.  Coexistence of endometrial mesonephric-like adenocarcinoma and endometrioid carcinoma suggests a Müllerian duct lineage: a case report , 2019, Diagnostic Pathology.

[4]  J. K. Schoolmeester,et al.  Corded and hyalinized mesonephric-like adenocarcinoma of the uterine corpus: report of a case mimicking endometrioid carcinoma. , 2019, Human pathology.

[5]  M. Nucci,et al.  A Combined Morphologic and Molecular Approach to Retrospectively Identify KRAS-Mutated Mesonephric-like Adenocarcinomas of the Endometrium , 2019, The American journal of surgical pathology.

[6]  B. Gilks,et al.  A Comparison of GATA3, TTF1, CD10, and Calretinin in Identifying Mesonephric and Mesonephric-like Carcinomas of the Gynecologic Tract , 2018, The American journal of surgical pathology.

[7]  L. Macconaill,et al.  Targeted Genomic Profiling Reveals Recurrent KRAS Mutations in Mesonephric-like Adenocarcinomas of the Female Genital Tract , 2018, The American journal of surgical pathology.

[8]  M. Nucci,et al.  Mesonephric proliferations of the female genital tract. , 2017, Pathology.

[9]  T. Krausz,et al.  An Ovarian Adenocarcinoma With Combined Low-grade Serous and Mesonephric Morphologies Suggests a Müllerian Origin for Some Mesonephric Carcinomas , 2017, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[10]  W. McCluggage,et al.  Ovarian Combined Low-grade Serous and Mesonephric-like Adenocarcinoma: Further Evidence for A Mullerian Origin of Mesonephric-like Adenocarcinoma. , 2018, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[11]  W. McCluggage,et al.  Hormone receptor‐negative, thyroid transcription factor 1‐positive uterine and ovarian adenocarcinomas: report of a series of mesonephric‐like adenocarcinomas , 2016, Histopathology.

[12]  L. Macconaill,et al.  Targeted genomic profiling reveals recurrent KRAS mutations and gain of chromosome 1q in mesonephric carcinomas of the female genital tract , 2015, Modern Pathology.

[13]  Y. Sajjad Development of the genital ducts and external genitalia in the early human embryo , 2010, The journal of obstetrics and gynaecology research.

[14]  B. Mellado,et al.  Activity of chemotherapy with carboplatin plus paclitaxel in a recurrent mesonephric adenocarcinoma of the uterine corpus. , 2003, Gynecologic oncology.